Clinical Trials in Georgia

Showing 9221-9240 of 19,050 trials

Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation

NCT04110145

The purpose of this study is to evaluate the dose response, safety, and efficacy of linaclotide when compared with placebo in pediatric participants, 2 to 5 years of age, with Functional Constipation.

Functional Constipation

Allergan35 participantsStarted Oct 2019

Birmingham, Alabama, United States • Hot Springs, Arkansas, United States • Little Rock, Arkansas, United States +15 more locations

TERMINATEDPhase 365 miles

Phase 3 Extension Study of Dexpramipexole in ALS

NCT01622088

The purpose of the study is to collect long-term safety data from subjects with Amyotrophic Lateral Sclerosis (ALS) exposed to dexpramipexole.

Amyotrophic Lateral Sclerosis

Knopp Biosciences616 participantsStarted Jun 2012

Phoenix, Arizona, United States • Fresno, California, United States • Orange, California, United States +77 more locations

Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation

Phase 3 Extension Study of Dexpramipexole in ALS

Find Trials by Condition in Georgia

Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis

Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)

OsseoFix™ Spinal Fracture Reduction System in Treating Spinal Compression Fracture

A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma

Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults

Short-term Clinical Deterioration After Acute Pulmonary Embolism

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors

Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women

CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines

Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers

Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid Malignancies

Steroid Sensitive Nephrotic Syndrome in Children

Study of the Safety and Efficacy of MIW815 With PDR001 in Patients With Advanced/Metastatic Solid Tumors or Lymphomas

Decision Aid for Renal Therapy

Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer